ALAB vs TER: which is the better buy in 2026?
On Alexandria's Compass, Astera Labs, Inc. has the edge with a 93/100 score versus 91/100 for TER. Here is how they stack up, factor by factor.
Astera Labs, Inc.
NASDAQ:ALAB
The connectivity tax on every AI rack is real, but you're paying for three years of perfect execution at today's price.
Full ALAB analysisTeradyne, Inc.
NASDAQ:TER
The HBM test bottleneck has a name, and Teradyne owns the socket Nvidia's supply chain can't ship without.
Full TER analysisFactor by factor
Get head-to-heads like this, free
Join the Alexandria e-letter for Compass verdicts, earnings intelligence, and the contrarian calls the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is ALAB or TER the better buy in 2026?
By Compass Score, Astera Labs, Inc. (NASDAQ:ALAB) edges it at 93/100 versus 91/100 for TER. Both scores update weekly and reflect a contrarian, forward-looking read, not a recommendation.
How does Alexandria compare ALAB and TER?
Each company is scored 1-100 on eight factors: revenue growth, profitability, valuation, momentum, theme purity, moat, catalysts, and market position. The Compass Score is the composite, and the comparison below shows where each name wins factor by factor.
Compass Scores are proprietary editorial research from publicly available data, not investment advice or a recommendation regarding any security. Rankings update weekly.